TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
鄭文芳Cheng, Wen-Fang
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
21筆
1
Chen JL, Huang CY, Huang YS, Hsu CY, Lan KH, Shih IL, Cheng WF, Chen CA, Sheu BC, Kuo SH. Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer. Cancers (Basel). 2021 Mar 18;13(6):1386. doi: 10.3390/cancers13061386. PMID: 33803915; PMCID: PMC8003240.
2
Kao TC, Mao TL, Cheng CY, Chen IH, Cheng WF. Rare clinical manifestations of primary peritoneal serous carcinoma presenting as colorectal cancer: A report of two cases. Taiwan J Obstet Gynecol. 2021 Mar;60(2):363-366. doi: 10.1016/j.tjog.2021.01.018. PMID: 33678344.
3
Shih IL, Yen RF, Chen CA, Cheng WF, Chen BB, Chang YH, Cheng MF, Shih TT. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival. J Magn Reson Imaging. 2021 Jan;53(1):305-318. doi: 10.1002/jmri.27311. Epub 2020 Aug 14. PMID: 32798280.
4
Lu HY, Tai YJ, Chen YL, Chiang YC, Hsu HC, Cheng WF. Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients. J Gynecol Oncol. 2021 Mar;32(2):e18. doi: 10.3802/jgo.2021.32.e18. Epub 2020 Dec 3. PMID: 33327048; PMCID: PMC7930441.
5
Lu HY, Tai YJ, Chen YL, Chiang YC, Hsu HC, Cheng WF. Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients. J Gynecol Oncol. 2021 Mar;32(2):e18. doi: 10.3802/jgo.2021.32.e18. Epub 2020 Dec 3. PMID: 33327048; PMCID: PMC7930441.
6
Chen JL, Huang YS, Huang CY, Hsu CY, Lan KH, Cheng WF, Kuo SH. Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study. Radiat Oncol. 2020 Apr 6;15(1):72. doi: 10.1186/s13014-020-01523-5. PMID: 32252781; PMCID: PMC7137232.
7
Lee CY, Chen YL, Chiang YC, Cheng CY, Lai YL, Tai YJ, Hsu HC, Hwa HL, Cheng WF. Outcome and Subsequent Pregnancy after Fertility-Sparing Surgery of Early-Stage Cervical Cancers. Int J Environ Res Public Health. 2020 Sep 28;17(19):7103. doi: 10.3390/ijerph17197103. PMID: 32998288; PMCID: PMC7579067.
8
Kang JH, Lai YL, Cheng WF, Kim HS, Kuo KT, Chen YL, Lee YY. Clinical factors associated with prognosis in low-grade serous ovarian carcinoma: experiences at two large academic institutions in Korea and Taiwan. Sci Rep. 2020 Nov 17;10(1):20012. doi: 10.1038/s41598-020-77075-1. PMID: 33203969; PMCID: PMC7672053.
9
Sun NY, Chen YL, Wu WY, Lin HW, Chiang YC, Chang CF, Tai YJ, Hsu HC, Chen CA, Sun WZ, Cheng WF. Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization. Cancers (Basel). 2019 Sep 19;11(9):1400. doi: 10.3390/cancers11091400. PMID: 31546897; PMCID: PMC6769724.
10
Li YP, Chang K, Chen TW, Lee SP, Chen CA, Cheng WF. Primary Ewing Family of Tumor Arising in the Ovary: A Case Report. Int J Gynecol Pathol. 2019 Sep;38(5):470-473. doi: 10.1097/PGP.0000000000000536. PMID: 30085939.
